An iterative adaptive weighted filtered backprojection (FBP) approach was applied to our photoacoustic imaging (PAI) of the optical absorption in biological tissues from limited-view data. By using an image-based adaptive weighted PAI reconstruction, we can modify the defect of the artifacts degrading the quality of the image. Results of numerical simulations demonstrated that the proposed algorithm was superior to FBP in terms of both accuracy and robustness to noise. Reconstructed images of biological tissues agreed well with the structures of the samples. The resolution of the PAI system with the proposed method was experimentally demonstrated to be better than 0.14 mm. By using the proposed method, the imaging quality of the PAI system can be improved.

Photoacoustic imaging (PAI) has been employed to reconstruct endogenous optical contrast present in tissues. At the cost of longer calculations, a compressive sensing reconstruction scheme can achieve artifact-free imaging with fewer measurements. In this paper, an effective acceleration framework using the alternating direction method (ADM) was proposed for recovering images from limited-view and noisy observations. Results of the simulation demonstrated that the proposed algorithm could perform favorably in comparison to two recently introduced algorithms in computational efficiency and data fidelity. In particular, it ran considerably faster than these two methods. PAI with ADM can improve convergence speed with fewer ultrasonic transducers, enabling a high-performance and cost-effective PAI system for biomedical applications.

As a new modality of molecular imaging, bioluminescence imaging has been widely used in tumor detection and drug evaluation. However, BLI cannot present the depth of information for internal diseases such as a liver tumor in situ or a lung tumor in situ. In this paper, we describe a bioluminescence tomography (BLT) method based on the bioluminescent intensity attenuation calibration and applied it to the early detection of liver cancer in situ. In comparison with BLT without calibration, this method could improve the reconstruction accuracy by more than 10%. In comparison with micro-computed tomography and other traditional imaging modalities, this method can detect a liver tumor at a very early stage and provide reliable location information.

In vivo bioluminescence imaging provides a high-sensitivity, low noise background, noninvasive means of monitoring genes, protein expression and other cellular events at a low cost.^1,2 However, this two-dimensional (2-D) imaging modality cannot provide three-dimensional (3-D) location information of the bioluminescent source. As a 3-D imaging modality, bioluminescence tomography (BLT) shows its advantage in determining the inner bioluminescent source distribution.³ 4. ^{– 5}